American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 5(65), 2021
DOI: 10.1128/aac.02631-20
Full text: Download
Stenotrophomonas maltophilia is an emerging cause of serious infections with high associated mortality in immunocompromised patients. Treatment of S. maltophilia infections is complicated by intrinsic resistance to many antimicrobials, including carbapenems, aminoglycosides, and some cephalosporins.